Combination of PTC209@VNP-HA plus cisplatin significantly inhibited tumor volume and weight growth compared to the cisplatin alone, suggesting that BMI1 inhibition overcomes cisplatin resistance in HNSCC in vivo (Fig. 6d–f). The gene discussed is BMI1; the disease is neoplasm.